Tar Heel biotech firms say they need incentives to compete with companies based in other states, but with a projected $3.7 billion budget shortfall, North Carolina might not be able to afford it.
“Innovation” was an oft-mentioned buzzword at the annual Emerging Issues Forum, an event sponsored by North Carolina State University that this year focuses on healthcare.
Underlying the discussion about health practices and new drugs is the subtle suggestion that more investment and support is needed from the state. The topic may gather even more attention this week as lawmakers return to Raleigh to start the legislative session.
Get the complete picture with a MassDevice Plus membership. Registered users can login here.